Results 1 to 10 of about 522,380 (253)

The variable use of heparin through intravenous bolus and flush fluid systems during endovascular stroke treatment, a world-wide survey [PDF]

open access: yesCVIR Endovascular
Background The total amount of heparin administered through flush fluids in stroke patients is not considered in recent trials, possibly influencing main results. We investigated the use of heparin among treating physicians worldwide.
Senta Frol   +5 more
doaj   +2 more sources

Delayed-onset heparin-induced thrombocytopenia presenting with multiple arteriovenous thromboses: case report [PDF]

open access: yesJournal of Medical Case Reports, 2007
Background Delayed-onset heparin-induced thrombocytopenia with thrombosis, albeit rare, is a severe side effect of heparin exposure. It can occur within one month after coronary artery bypass grafting (CABG) with manifestation of different thrombotic ...
Omran Abbas   +3 more
doaj   +4 more sources

Life-threatening hemorrhage following subcutaneous heparin therapy [PDF]

open access: yesTherapeutics and Clinical Risk Management, 2008
Jana Hudcova, Daniel TalmorDepartment of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USAAbstract: Prophylactic administration of unfractionated heparin is a common practice in ...
Jana Hudcova, Daniel Talmor
doaj   +3 more sources

Proteomic Identification and Functional Analysis of Babesia microti Reveals Heparin-Binding Proteins [PDF]

open access: yesJournal of Tropical Medicine
Glycosaminoglycan (GAG) molecules on the surface of red blood cells play an important regulatory role in the invasion of merozoites of apicomplexan protozoa.
Yu Chun Cai   +9 more
doaj   +2 more sources

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia

open access: yesThrombosis Journal, 2021
Background This is a review article on heparin-induced thrombocytopenia, an adverse effect of heparin therapy, and vaccine-induced immune thrombotic thrombocytopenia, occurring in some patients administered certain coronavirus vaccines.
Payel Datta   +3 more
doaj   +1 more source

Influence of different levels of heparin and antithrombin Ⅲ on human coagulation factor Ⅸ activity

open access: yesZhongguo shuxue zazhi, 2022
Objective To study the effect of different concentrations of heparin, ATⅢ or a mixture of heparin and antithrombin Ⅲ (ATⅢ) (1∶1)on the activity of human coagulation factor Ⅸ (FⅨ).
Changyong JIAN   +5 more
doaj   +1 more source

Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin

open access: yesFrontiers in Medicine, 2020
The USP heparin sodium monograph lists impurities with specifications developed for porcine derived products. Most of these impurities are of biological origin and are present in porcine intestinal mucosa, the tissue source used in the production of ...
Wesley E. Workman, Kevin L. Carrick
doaj   +1 more source

Heparin-induced thrombocytopenia occurring early after living donor liver transplantation: a case report

open access: yesEmergency and Critical Care Medicine, 2023
. Background. Thrombocytopenia commonly occurs early after liver transplantation. Heparin, usually administered as anticoagulant therapy for thrombosis, a common complication after liver transplantation, may cause heparin-induced thrombocytopenia ...
Naoya Iwasaki   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy